Efficacy and safety of morinidazole in pelvic inflammatory disease: results of a multicenter, double-blind, randomized trial
Crossref DOI link: https://doi.org/10.1007/s10096-017-2913-z
Published Online: 2017-03-06
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cao, C. https://orcid.org/0000-0002-3739-5240
Luo, A.
Wu, P.
Weng, D.
Zheng, H.
Wang, S.
License valid from 2017-03-06